These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1375811)

  • 1. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
    Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
    Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker.
    Spencer K; Mallard AS; Coombes EJ; Macri JN
    BMJ; 1993 Dec; 307(6917):1455-8. PubMed ID: 7506599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
    Schmidt D; Shaffer LG; McCaskill C; Rose E; Greenberg F
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):77-80. PubMed ID: 7507646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
    Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
    Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
    Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
    Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
    Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
    Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
    Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
    Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
    Lieppman RE; Williams MA; Cheng EY; Resta R; Zingheim R; Hickok DE; Luthy DA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1852-6; discussion 1856-7. PubMed ID: 8317532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advantages of using triple-marker screening for chromosomal abnormalities.
    Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
    Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.
    Saller DN; Canick JA; Kellner LH; Rose NC; Garza J; French CA; Mooney RA
    Am J Obstet Gynecol; 1997 Oct; 177(4):879-81. PubMed ID: 9369838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
    Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.